Charisma Medical and Research Center | Miami Lakes, FL

Research site
5979 NW 151 Street, Suite 104, Miami Lakes, Florida, United States of America
Site insights

Top conditions

Systemic Lupus Erythematosus (4 trials)

Acute Kidney Injury (1 trial)

Arthritis (1 trial)

Clostridium Infections (1 trial)

Cutaneous Lupus Erythematosus (1 trial)

Top treatments

Tc 99m

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


6 of 9
Status: Active
Trial type: Interventional
Funder type: Industry

A Study to Assess the Efficacy and Safety of BIIB059 (Litifilimab) in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST)

The primary objectives of the study are to evaluate the efficacy of BIIB059 (litifilimab) compared with placebo in reducing skin disease activity mea...

Subacute Cutaneous Lupus Erythematosus
Chronic Cutaneous Lupus Erythematosus
Drug: BIIB059 (litifilimab)
Drug: Placebo

The primary objective of this study is to demonstrate efficacy of litifilimab (BIIB059) compared with placebo in participants with active systemic lu...

Lupus Erythematosus, Systemic
Drug: Litifilimab
Drug: Placebo

Study TitleA phase 1b/2a multicenter, randomized, double-blind, placebo-controlled study to assess the safety and tolerability, pharmacokinetics and...

Active, not recruiting
SLE; Drug
Drug: KPG-818 mid dose
Drug: KPG-818 high dose

The purpose of VAN00010 study is to assess the safety and immunogenicity of the investigational pentavalent meningococcal ABCYW vaccine in adults and...

Meningococcal Infection
Healthy Volunteers
Biological: Pentavalent Meningococcal ABCYW vaccine
Biological: MenACYW conjugate vaccine

This study will confirm the ability of Tc 99m tilmanocept imaging to predict clinical response in individuals with RA who are beginning anti-TNFα the...

Rheumatoid Arthritis
Drug: TC99m-tilmanocept

The purpose of this Proof of Concept (PoC) and Dose-finding (DF) basket study is to evaluate the efficacy and safety of orally administered Enpatoran...

Systemic Lupus Erythematosus
Drug: Enpatoran low dose
Drug: Placebo

Trial sponsors

Biogen logo

Biogen (2 trials)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems